×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical: CpG1018 TLR9 Agonist Phase 1 Trial (NCT05606341)
clinical
922 words
KG: TLR9
2026-03-24
kind:clinical-trial
section:clinical-trials
state:published
Contents
CpG1018 TLR9 Agonist Phase 1 Trial (NCT05606341)
Knowledge Graph
Related Hypotheses (3)
Phase-Separated Organelle Targeting
Score: 0.52
Stress Granule Phase Separation Modulators
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Related Analyses (5)
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Related Experiments (1)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Knowledge Graph (12 edges)
TLR9
regulates
NET
TLR9
activates
MYD88
TLR9
activates
TLR4
TLR9
activates
TNF
TLR9
activates
TLR3
TLR9
associated_with
TNF
TLR9
regulates
NLRP3
TLR9
inhibits
TNF
TLR9
regulates
PPT1
TLR9
inhibits
TLR4